Literature DB >> 957481

Intermediates in adenovirus assembly.

B Edvardsson, E Everitt, H Jörnvall, L Prage, L Philipson.   

Abstract

Three intermediates in adenovirus assembly have been defined; nuclear intermediates, young virions, and mature virions. The nuclear intermediates are fragile and heterogenous in size (550S-670S) and withstand separation on ficoll gradients but fall apart upon CsCl gradient centrifugation unless prefixed with glutaraldehyde. They contain both capsid and core structures, and the core structures are preferentially released during purification in CsCl. The precursor polypeptides pVI and pVII are present in the intermediates without any corresponding mature polypeptide. The young virions (Ishibashi and Maizel, 1974) are stable and preferentially confined to the nuclei after cell fractionation. They contain both uncleaved precursor polypeptides and their cleavage products. The mature virions accumulate in the cytoplasm during cell fractionation and contain the final mature polypeptides. Pulse-chase labeling kinetics, focusing on the precursor polypeptides, suggest that these three classes participate in assembly of adenovirus. Tryptic peptide maps establish that polypeptide pVI is the precursor of polypeptide VI, but only a small fraction of polypeptide 26K can in vivo account for polypeptide VIII.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 957481      PMCID: PMC354890          DOI: 10.1128/JVI.19.2.533-547.1976

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Amino acid metabolism in mammalian cell cultures.

Authors:  H EAGLE
Journal:  Science       Date:  1959-08-21       Impact factor: 47.728

2.  STUDIES ON ADENOVIRUS-12. I. QUANTITATIVE CORRELATIONS BETWEEN SOME PHYSICAL, ANTIGENIC AND INFECTIOUS PROPERTIES.

Authors:  K O SMITH
Journal:  J Immunol       Date:  1965-06       Impact factor: 5.422

3.  Studies on the biosynthesis of viral DNA.

Authors:  M GREEN
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1962

4.  Structural proteins of adenoviruses. X. Isolation and topography of low molecular weight antigens from the virion of adenovirus type 2.

Authors:  E Everitt; B Sundquist; U Pettersson; L Philipson
Journal:  Virology       Date:  1973-03       Impact factor: 3.616

5.  Isopycnic separation of subcellular components from poliovirus-infected and normal HeLa cells.

Authors:  D Baltimore; A S Huang
Journal:  Science       Date:  1968-11-01       Impact factor: 47.728

6.  The polypeptides of adenovirus. II. Soluble proteins, cores, top components and the structure of the virion.

Authors:  J V Maizel; D O White; M D Scharff
Journal:  Virology       Date:  1968-09       Impact factor: 3.616

7.  Isolation of temperature-sensitive mutants of adenovirus type 5.

Authors:  J F Williams; M Gharpure; S Ustacelebi; S McDonald
Journal:  J Gen Virol       Date:  1971-05       Impact factor: 3.891

8.  Structural proteins of adenoviruses. IV. Sequential degradation of the adenovirus type 2 virion.

Authors:  L Prage; U Pettersson; S Höglund; K Lonberg-Holm; L Philipson
Journal:  Virology       Date:  1970-10       Impact factor: 3.616

9.  Gene expression during the development of bacteriophage phi 29. 3. Analysis of viral-specific protein synthesis with suppressible mutants.

Authors:  J C McGuire; J J Pène; J Barrow-Carraway
Journal:  J Virol       Date:  1974-03       Impact factor: 5.103

10.  Electron microscopic and histochemical studies of an unusual crystalline protein occurring in cells infected by type 5 adenovirus.

Authors:  C MORGAN; G C GODMAN; H M ROSE; C HOWE; J S HUANG
Journal:  J Biophys Biochem Cytol       Date:  1957-05-25
View more
  50 in total

1.  Interaction of the adenovirus IVa2 protein with viral packaging sequences.

Authors:  W Zhang; M J Imperiale
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Mechanism of scaffolding-directed virus assembly suggested by comparison of scaffolding-containing and scaffolding-lacking P22 procapsids.

Authors:  P A Thuman-Commike; B Greene; J A Malinski; M Burbea; A McGough; W Chiu; P E Prevelige
Journal:  Biophys J       Date:  1999-06       Impact factor: 4.033

3.  Adenovirus L1 52- and 55-kilodalton proteins are present within assembling virions and colocalize with nuclear structures distinct from replication centers.

Authors:  T B Hasson; D A Ornelles; T Shenk
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

4.  Intracellular forms of simian virus 40 nucleoprotein complexes. II. Biochemical and electron microscopic analysis of simian virus 40 virion assembly.

Authors:  M Coca-Prados; M T Hsu
Journal:  J Virol       Date:  1979-07       Impact factor: 5.103

5.  Analysis of the interaction of the adenovirus L1 52/55-kilodalton and IVa2 proteins with the packaging sequence in vivo and in vitro.

Authors:  Pilar Perez-Romero; Ryan E Tyler; Johanna R Abend; Monica Dus; Michael J Imperiale
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

6.  Formation of a multiple protein complex on the adenovirus packaging sequence by the IVa2 protein.

Authors:  Ryan E Tyler; Sean G Ewing; Michael J Imperiale
Journal:  J Virol       Date:  2007-01-17       Impact factor: 5.103

7.  Adenovirus IVa2 protein binds ATP.

Authors:  Philomena Ostapchuk; Patrick Hearing
Journal:  J Virol       Date:  2008-07-30       Impact factor: 5.103

8.  Regulation of the biosynthesis of subgroup C adenovirus protein IVa2.

Authors:  N Winter; J C D'Halluin
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

9.  Virus-receptor interaction in the adenovirus system: characterization of the positive cooperative binding of virions on HeLa cells.

Authors:  R Persson; C Wohlfart; U Svensson; E Everitt
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

10.  Serotype 5 Adenovirus fiber (F7F41S) chimeric vectors incur packaging deficiencies when targeting peptides are inserted into Ad41 short fiber.

Authors:  John W Schoggins; Erik Falck-Pedersen
Journal:  Virology       Date:  2009-09-25       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.